MKMichael Kirby

Michael Kirby

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Kirby has a total of 174 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)

    by Kevan Richard Wylie, Michael G Kirby, Filippo Maria Nimbi, Michael Krychman, Jennifer Barsky Reese, Deborah C Marshall

    Introduction: Disorders of chronic illness and certain cancers are common and can pose a substantial burden to the individual and their sexual partners. Objectives: This manuscript reviews the substantial impact of chronic illness and cancer on sexual function from the perspectives of patients, partners, and healthcare providers. Convened by the Fifth International Consultation on Sexual Medicine, a multidisciplinary panel conducted a narrative review of current literature and expert consensus. The findings highlight both the direct and indirect effects of chronic diseases, breast and gynecological cancers, and oncological treatments on sexual health and relationships, emphasizing the importance of recognizing and addressing these issues to optimize care for individuals and their partners. Methods: Narrative review of the existing literature and consensus recommendations from the expert panel. Results: The direct and indirect impact of chronic disease and cancers and the impact of associated treatment interventions on sexual function and relationships is considerable. Conclusions: An understanding of the impact of chronic illness and cancers, and the related treatment of such can aid clinicians and researchers in providing optimal care to the individual and their partner(s).

  • Open Access

    Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions

    by Alexandra Naranjo, Geoffrey Ian Hackett, Sophie Smith, Harley Stephens, William Kinnaird, Mike Kirby

    Naranjo A, et al. World J Mens Health. 2026 Feb;44:e20. https://doi.org/10.5534/wjmh.250313

  • Open Access

    British Society of Sexual Medicine: Position Statement for the Potential Use of Enclomiphene in the Treatment of Male Hypogonadism

    by Jeff Foster, Louis Choo, Anand Patel, Michael Kirby, Geoff Hackett

    Foster J, et al. World J Mens Health. 2026 Feb;44:e17. https://doi.org/10.5534/wjmh.250395


  • Open Access

    Testosterone Replacement Therapy in Hypogonadal Men with a Prostate Cancer Diagnosis: A British Society for Sexual Medicine Consensus Statement

    by Marie Alexandra Edison, Michael Kirby, Geoffrey Ian Hackett

    Edison MA, et al. World J Mens Health. 2026 Jan;44(1):5-22. https://doi.org/10.5534/wjmh.250086


  • Open Access

    British Society for Sexual Medicine (BSSM) Position Statement on Premature Ejaculation

    by Geoff Ian Hackett, Mike Kirby, Patricia Schartau, Nick Ossei-Gerning, Janine David, Wai Gin Lee

    Ian Hackett G, et al. World J Mens Health. 2025 Feb;43:e14. https://doi.org/10.5534/wjmh.240262


  • Open Access

    Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus

    by Thomas A Harding, Richard M Martin, Samuel Wd Merriel, Robert Jones, Joe M O’sUllivan, Mike Kirby, Oluwabunmi Olajide, Alexander Norman, Jaimin Bhatt, Oliver Hulson, et al.

    Background: Screening is not recommended for prostate cancer in the UK. Asymptomatic men aged ≥50 years can request a prostate-specific antigen (PSA) test following counselling on potential harms and benefits. There are areas of clinical uncertainty among GPs, resulting in the content and quality of counselling varying. Aim: To produce a consensus that can influence guidelines for UK primary care on the optimal use of the PSA test in asymptomatic men for early prostate cancer detection. Design and setting: Prostate Cancer UK facilitated a RAND/UCLA consensus. Method: Statements covering five topics were developed with a subgroup of experts. A panel of 15 experts in prostate cancer scored (round one) statements on a scale of one (strongly disagree) to nine (strongly agree). Panellists met to discuss statements before rescoring (round two). A lived experience panel of seven men scored a subset of statements with outcomes fed into the main panel. Results: Of the initial 94 statements reviewed by the expert panel, a final 48/85 (56%) achieved consensus. In the absence of screening, there was consensus on proactive approaches to initiate discussions about the PSA test with men who were at higher-than-average risk. Conclusion: Improvements in the prostate cancer diagnostic pathway may have reduced some of the harms associated with PSA testing; however, several areas of uncertainty remain in relation to screening, including optimal PSA thresholds for referral and intervals for retesting. There is consensus on proactive approaches to testing in higher-than-average risk groups. This should prompt a review of current guidelines.


  • Open Access

    Is the digital rectal exam any good as a prostate cancer screening test?

    by Mike Kirby, Samuel Wd Merriel, Oluwabunmi Olajide, Alexander Norman, Nikhil Vasdev, Vishwanath Hanchanale, Michelle Cain, Malcolm Wilkinson, Harley Stephens, Deborah Victor, et al.


  • Open Access

    Effects of a Brief E-Learning Resource on Sexual Attitudes and Beliefs of Healthcare Professionals Working in Prostate Cancer Care: A Pilot Study

    by Eilís M. McCaughan, Carrie Flannagan, Kader Parahoo, Sharon L. Bingham, Nuala Brady, John Connaghan, Roma Maguire, Samantha Thompson, Suneil Jain, Michael Kirby, et al.

    Sexual issues and treatment side effects are not routinely discussed with men receiving treatment for prostate cancer, and support to address these concerns is not consistent across settings. This study evaluates a brief e-learning resource designed to improve sexual wellbeing support and examine its effects on healthcare professionals’ sexual attitudes and beliefs. Healthcare professionals (n = 44) completed an online questionnaire at baseline which included a modified 12-item sexual attitudes and beliefs survey (SABS). Follow-up questionnaires were completed immediately after the e-learning and at 4 weeks. Data were analysed using one-way, repeat measures ANOVAs to assess change in attitudes and beliefs over time. Significant improvements were observed at follow-up for a number of survey statements including ‘knowledge and understanding’, ‘confidence in discussing sexual wellbeing’ and the extent to which participants felt ‘equipped with the language to initiate conversations’. The resource was seen as concise, relevant to practice and as providing useful information on potential side effects of treatment. In brief, e-learning has potential to address barriers to sexual wellbeing communication and promote delivery of support for prostate cancer survivors. Practical methods and resources should be included with these interventions to support implementation of learning and long-term changes in clinical behaviour.


  • Open Access

    Efficacy, Use, and Acceptability of a Web-Based Self-management Intervention Designed to Maximize Sexual Well-being in Men Living With Prostate Cancer: Single-Arm Experimental Study

    by Sean R O'Connor, Carrie Flannagan, Kader Parahoo, Mary Steele, Samantha Thompson, Suneil Jain, Michael Kirby, Nuala Brady, Roma Maguire, John Connaghan, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Sexual dysfunction is a frequent side-effect associated with different prostate cancer treatment approaches. It can have a substantial impact on men and partners and is associated with increased psychological morbidity. Despite this, sexual concerns are often not adequately addressed in routine practice. Evidence-based online interventions have potential to provide ongoing information and sexual wellbeing support throughout all stages of care. Objective: To examine the efficacy of an online self-management intervention designed to maximise sexual wellbeing in men living with prostate cancer and explore user perspectives on usability and acceptability. Methods: Using a single-arm study design, participants were provided with access to the five-step intervention for a period of 3 months. Intervention content was tailored based on responses to brief screening questions on treatment type, relationship status and sexual orientation. Efficacy was assessed using paired-sample t-tests comparing mean differences between pre and post intervention survey measurements exploring participant’s self-reported knowledge and understanding, sexual satisfaction, and comfort discussing sexual issues. Usability and acceptability were determined based on programme usage data and a post intervention survey exploring perceived usefulness. Results: A total of 109 participants were recruited to the study. Significant post intervention improvements at follow-up were observed in overall survey scores (12.23/20 (SD: 2.46) versus 13.62/20 (SD: 2.31): t = 9.570; P =0.001) as well as in individual item scores on the extent to which participants agreed that they had sufficient information to manage the impact of prostate cancer on their sex life (2.31/4 (SD: 0.86) versus 2.57/4 (SD: 0.85): t = 3.660; P =0.001) and had the potential to have a satisfying sex life following treatment (2.38/4 (SD: 0.79) versus 3.17/4 (SD: 0.78): t = 7.643; P =0.001). The median number of intervention sessions was 3.0 (Range 1 to 11 sessions) with a median duration of 22.0 minutes (Range: 8 to 77 minutes). Acceptable usability scores were reported with the highest agreement observed for the question on the extent to which the intervention provided relevant information. Conclusions: This study provides evidence for the efficacy of a tailored, online intervention to maximise sexual wellbeing in men living with prostate cancer. Results indicated that the intervention may improve self-perceived knowledge and understanding of how to manage sexual issues, and increase self-efficacy or a belief that a satisfactory sex life could achieved following treatment. Findings will be used to refine content prior to testing as part of a larger longitudinal study examining intervention effectiveness. Clinical Trial: N/a


  • Open Access

    The Tablet-Based, Engagement, Assessment, Support, and Sign-Posting (EASSi) Tool for Facilitating and Structuring Sexual Well-Being Conversations in Routine Prostate Cancer Care: Mixed-Methods Study

    by Eilís McCaughan, Carrie Flannagan, Kader Parahoo, John Connaghan, Roma Maguire, Mary Steele, Samantha Thompson, Suneil Jain, Michael Kirby, Nuala Brady, et al.

    Background: Long-term side-effects associated with different prostate cancer treatment approaches are common. Sexual challenges are the most frequently occurring issues and can result in increased psychological morbidity. It is recognized that barriers to communication can make initiating discussions around sexual concerns in routine practice difficult. Health care professionals need to routinely initiate conversations, effectively engage with patients, and assess needs in order to provide essential support. One proposed method that could support health care professionals to do this involves the use of prompts or structured frameworks to guide conversations. Objective: This study aimed to assess feasibility, acceptability, and satisfaction with the tablet-based Engagement, Assessment, Support, and Sign-posting (EASSi) tool designed to facilitate and structure sexual well-being discussions in routine prostate cancer care. Methods: Health care professionals (n=8) used the EASSi tool during 89 posttreatment appointments. Quantitative data were recorded based on program usage and surveys completed by health care professionals and patients. Qualitative data exploring perceptions on use of the tool were gathered using semistructured interviews with all health care professionals (n=8) and a sample of patients (n=10). Results: Surveys were completed by health care professionals immediately following each appointment (n=89, 100%). Postal surveys were returned by 59 patients (66%). Health care professionals and patients reported that the tool helped facilitate discussions (81/89, 91% and 50/59, 85%, respectively) and that information provided was relevant (82/89, 92% and 50/59, 85%, respectively). The mean conversation duration was 6.01 minutes (SD 2.91). Qualitative synthesis identified the tool’s ability to initiate and structure discussions, improve the “depth” of conversations, and normalize sexual concerns. Conclusions: The EASSi tool was appropriate and acceptable for use in practice and provided a flexible approach to facilitate routine brief conversations and deliver essential sexual well-being support. Further work will be conducted to evaluate the effectiveness of using the tablet-based tool in prostate cancer care settings.